# Crocins Ameliorate Experimental Immune Checkpoint Inhibitor-Related Myocarditis by Targeting the Hpx/Nrf2/HO-1 Pathway

**Authors:** Jing Yan, Qingqing Cai, Yu Li, Yi Zhang, Ye Zhao, Fangbo Zhang, Huamin Zhang

PMC · DOI: 10.3390/ijms27020911 · 2026-01-16

## TL;DR

This study shows that crocins from saffron can reduce heart inflammation caused by cancer treatments by targeting a specific biological pathway.

## Contribution

The novel finding is that crocins ameliorate ICI-related myocarditis via the Hpx/Nrf2/HO-1 pathway, supported by proteomics and molecular docking.

## Key findings

- Crocins improved cardiac function and reduced myocardial damage in a mouse model of ICI-related myocarditis.
- Crocins suppressed oxidative stress and inflammatory responses, as confirmed by proteomics and Western blotting.
- Molecular docking identified specific interactions between crocins and proteins in the Hpx/Nrf2/HO-1 pathway.

## Abstract

Immune checkpoint inhibitors (ICIs) for cancer therapy may induce immune-related adverse events including myocarditis, which occurs infrequently but carries a high mortality rate. Crocins are the active constituents derived from Crocus sativus L. (saffron), and have demonstrated various bioactivities including anti-tumor, anti-inflammation, antioxidation, anti-ischemia, anti-aging, and neuroprotective effects. This study established a subcutaneous xenotransplanted tumor model of human liver cancer in nude mice to better mimic ICI-related myocarditis. Animal experimental results revealed that crocins improved cardiac function, relieved myocardial damage and autoimmune response, and suppressed oxidative stress and inflammatory reaction. Quantitative proteomics and Western blotting verification confirmed that crocins ameliorated experimental ICI-related myocarditis by targeting the Hpx/Nrf2/HO-1 pathway. Molecular docking revealed that the best docking activities were demonstrated by crocin I–HO-1, crocin II–Hpx, and crocin III–Nrf2. These findings shed new light on the development of therapeutic strategies for treating ICI-related myocarditis and provided the fundamental basis for expanding the clinical application of crocins.

## Linked entities

- **Proteins:** HPX (hemopexin), GABPA (GA binding protein transcription factor subunit alpha), HMOX1 (heme oxygenase 1)
- **Diseases:** myocarditis (MONDO:0004496), liver cancer (MONDO:0002691)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, HPX (hemopexin) [NCBI Gene 3263] {aka HX}
- **Diseases:** autoimmune response (MESH:D001327), liver cancer (MESH:D006528), cancer (MESH:D009369), Myocarditis (MESH:D009205), ischemia (MESH:D007511), inflammation (MESH:D007249), myocardial damage (MESH:D009202)
- **Chemicals:** crocin I (-), Crocins (MESH:C029036)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Crocus sativus (saffron crocus, species) [taxon 82528]

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12841150/full.md

---
Source: https://tomesphere.com/paper/PMC12841150